| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +100.00% | -7.72% | +1.02% | -8.74% | -8.74% | — |
| 14d | 2 | +100.00% | -5.90% | +1.99% | -7.89% | -7.89% | — |
| 30d | 2 | +100.00% | -10.89% | +2.27% | -5.83% | -5.83% | — |
| 60d | 2 | +100.00% | -3.00% | +4.08% | -7.08% | -7.08% | — |
| 90d | 2(1 pending) | +100.00% | -21.17% | +1.09% | -22.26% | -22.26% | — |
| 180d | 2(1 pending) | +100.00% | -33.92% | — | — | — | — |
| 1y | 2(2 pending) | — | — | — | — | — | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| RGEN REPLIGEN CORP | SALE10b5-1 10b5-1 plan | 3,832 | $140.00 | $536.5K | 54,246 | Apr 21, 2026 | Apr 22, 2026 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 24,134 | — | — | 58,078 | Mar 5, 2026 | Mar 23, 2026 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 25,890 | — | — | 25,890 | Mar 5, 2026 | Mar 23, 2026 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Executive Officer | 1,610 | $124.97 | $201.2K | 33,944 | Mar 2, 2026 | Mar 3, 2026 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Executive Officer | 344 | $128.73 | $44.3K | 35,554 | Feb 27, 2026 | Mar 3, 2026 ↗ | View → |
| RGEN REPLIGEN CORP | SALE10b5-1 10b5-1 plan | 7,041 | $170.00 | $1.20M | 35,898 | Nov 25, 2025 | Nov 26, 2025 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Executive Officer | 1,248 | $145.23 | $181.2K | 42,939 | Oct 2, 2025 | Oct 6, 2025 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Executive Officer | 2,506 | $116.18 | $291.1K | 44,187 | Sep 3, 2025 | Sep 4, 2025 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 14,480 | — | — | 46,693 | Mar 3, 2025 | Mar 4, 2025 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 13,627 | — | — | 13,627 | Mar 3, 2025 | Mar 4, 2025 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Executive Officer | 343 | $156.54 | $53.7K | 32,213 | Feb 27, 2025 | Feb 28, 2025 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Executive Officer | 861 | $123.41 | $106.3K | 32,556 | Nov 20, 2024 | Nov 21, 2024 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 17,631 | — | — | 33,417 | Sep 3, 2024 | Sep 4, 2024 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 16,278 | — | — | 16,278 | Sep 3, 2024 | Sep 4, 2024 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 2,860 | — | — | 2,860 | Feb 27, 2024 | Feb 29, 2024 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 2,880 | — | — | 15,786 | Feb 27, 2024 | Feb 29, 2024 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 24,236 | — | — | 24,236 | Oct 2, 2023 | Oct 3, 2023 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 12,906 | — | — | 12,906 | Oct 2, 2023 | Oct 3, 2023 ↗ | View → |